1-(3,4-dihydrobenzo[b][1,4]thiazepin-5(2H)-yl)-3-((3,4-dimethoxyphenethyl)amino)propan-1-one(WXG03178);1-(3,4-dihydrobenzo[b][1,4]thiazepin-5(2H)-yl)-3-((3,4-dimethoxyphenethyl)amino)propan-1-one;1-Propanone, 1-(3,4-dihydro-1,5-benzothiazepin-5(2H)-yl)-3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-;KT-362 free base
It is an intracellular calcium antagonist with antiarrhythmic and vasodilatory effects; KT-362 free acid antagonizes norepinephrine (NE)-induced vasoconstriction by inhibiting inositol phospholipid hydrolysis, thereby reducing intracellular calcium mobilization; it can be used to study the mechanisms of contraction and relaxation in vascular smooth muscle, particularly the roles of intracellular calcium mobilization and inositol phospholipid hydrolysis in vasoconstriction.